Damora Therapeutics, Inc. (DMRA) insider trading.
In Q3 2026, insiders at Damora Therapeutics, Inc. reported 3 non-derivative transactions on 4 Forms 3, 4 and 5: 1 open-market purchase worth $253K and 1 sale worth $7K.
- Transactions
- 3
- Purchases (P)
- 1
- Sales (S)
- 1
- Net shares, P minus S
- 12,255
- Insiders
- 2
- Last filed
- 2026-09-28
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Winslow Garrett | Officer · General Counsel | 2 | 0 | 1 |
| Jarrett Jennifer | Director, Officer · Director, President and CEO | 1 | 1 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-25 | Jarrett Jennifer | P (A) | 12,500 | $20.23 | 512,500 | Form 4 |
| 2026-07-06 | Winslow Garrett | S (D) | 245 | $29.98 | 2,289 | Form 4 |
| 2026-07-03 | Winslow Garrett | M (A) | 680 | — | 2,534 | Form 4 |
Transaction codes in this quarter
Get DMRA insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1800315&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · DMRA company page · Damora Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Damora Therapeutics, Inc. (DMRA)?
In Q3 2026, insiders at Damora Therapeutics, Inc. reported 3 non-derivative transactions on 4 Forms 3, 4 and 5: 1 open-market purchase worth $253K and 1 sale worth $7K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Damora Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/dmra.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.